sacuvan 49/51 film-coated tablet
sacubitril valsartan sodium on colloidal silicon - film-coated tablet - sacubitril 49mg valsartan sodium 51mg on - valsartan and sacubitril
entresto 49mg51mg tablets
novartis pharmaceuticals uk ltd - valsartan; sacubitril - tablet - 51mg ; 49mg
entresto 100mg film-coated tablet (eq. to sacubitril 48.6 mg and valsartan 51.4 mg sodium salt complex)
novartis healthcare philippines, inc.; distributor: novartis healthcare philippines, inc. - sacubitril-valsartan - film-coated tablet (eq. to sacubitril 48.6 mg and valsartan 51.4 mg sodium salt complex) - 100mg
entresto 50mg film-coated tablet (eq. to sacubitril 24.3 mg and valsartan 25.7 mg sodium salt complex)
novartis healthcare philippines, inc.; distributor: novartis healthcare philippines, inc. - sacubitril-valsartan - film-coated tablet (eq. to sacubitril 24.3 mg and valsartan 25.7 mg sodium salt complex) - 50mg
entresto 200mg film-coated tablet (eq. to sacubitril 97.2 mg and valsartan 102.8 mg sodium salt complex)
novartis healthcare philippines, inc.; distributor: novartis healthcare philippines, inc. - sacubitril-valsartan - film-coated tablet (eq. to sacubitril 97.2 mg and valsartan 102.8 mg sodium salt complex) - 200mg
vymada 50mg (eq. to sacubitril 24.3mg and valsartan 25.7mg sodium salt complex) film-coated tablet
novartis healthcare philippines, inc.; distributor: novartis healthcare philippines, inc. - sacubitril-valsartan - film-coated tablet - 50mg (eq. to sacubitril 24.3mg and valsartan 25.7mg sodium salt complex)
sacuvan 97mg/103mg film-coated tablet
sacubitril valsartan sodium on colloidal silicon - film-coated tablet - 97mg of sacubitril and 103 mg of valsartan - valsartan and sacubitril
entresto
novartis europharm limited - sacubitril, valsartan - heart failure - angiotensin ii antagonists, other combinations, agents acting on the renin-angiotensin system - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction.adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
neparvis
novartis europharm limited - sacubitril, valsartan - heart failure - agents acting on the renin-angiotensin system - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5.1).adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.1).
vymada film-coated tablet
novartis healthcare philippines, inc.; distributor: novartis healthcare philippines, inc. - sacubitril-valsartan - film-coated tablet - 100mg (eq. to sacubitril 48.6mg and valsartan 51.4mg sodium salt complex)